The Prescriptive Authority (RxP) Initiative in Ontario
Purchase of video access is SOLELY for Dr. Robert McGrath's talk.
Psychologists are in a unique, first-line position, due to the nature, length, frequency, and regularity of patient contacts, to appreciate both the need for prescription of psychotropic medications and tolerability, safety and efficacy evidence during pharmacotherapy. In addition, psychologists are skilled in applying appropriate and effective non-pharmacological interventions for mental, emotional, cognitive, behavioural, thought, and mood disorders. Gaps in the Ontario health system have resulted in prolonged wait times, poor accessibility, and an over-reliance on medication. Prescriptive authority for psychologists would improve access, facilitate the management of patients with mental, cognitive and behavioural problems to best-practice standards, reduce financial burden and wait times, increase opportunities and efficacy in collaborative health practices, and ensure patient safety. The Ontario Psychological Association (OPA) submitted a request to the Minister of Health to expand the scope of practice of psychologists to include prescriptive authority in November 2012. This workshop will provide an overview of the RxP initiative, education and training requirements, the OPA submission, and next steps.
Date This was held on Friday, November 1, 2013
Time 8:30 a.m. to 3:00 p.m
Place The Albany Club
(91 King Street East)
Main Dining Room
Dr. Robert McGrath, Ph.D., received his Doctorate in Clinical Psychology from Auburn University in 1984. He has served as a faculty member at Fairleigh Dickinson University (FDU) in Teaneck NJ, and is now a Professor in the university’s School of Psychology. He currently directs FDU's Certificate Program in Integrated Primary Care and APA-designated M.S. Program in Clinical Psychopharmacology, and is the former director of the university’s APA-accredited Ph.D. Program in Clinical Psychology.
Dr. McGrath also maintains an active research program in methodology, measurement, and professional issues. In the last two years he has authored one book, Quantitative Models in Psychology, and co-edited a second, Pharmacotherapy for Psychologists: Prescribing and Collaborative Roles. He is a contributor to APA Books’ multi-volume reference The Handbook of Research Methods in Psychology, and has authored over 200 publications and presentations. He has received multiple awards for his work, including the university’s Distinguished Faculty Award for Research and Scholarship, Division 55’s Award for Outstanding Contribution to Prescriptive Authority on the National Level, the New Jersey Psychological Association's Psychologist of the Year, and the Society for Personality Assessment’s Martin Mayman Award for distinguished contribution to the literature in personality assessment.
Dr. McGrath is a former president of APA Division 55 (American Society for the Advancement of Pharmacotherapy), and currently serves as a member of APA’s Council of Representatives for the division. He is also a member or fellow of APA Divisions 5, 8, 12, and 38 and the APA Finance Committee. He is a member of the APA Advisory Group on State Implementation of Health Care Reform Initiatives, the Chair of the New Jersey Psychological Association Task Force on Health Care Reform, and Vice Chair of the APA Designation Committee for Postdoctoral Education and Training Programs in Psychopharmacology for Prescriptive Authority.
Dr. Marie Greenspan, Ph.D., MSCP., is a New Mexico Conditional Prescribing Psychologist employed by the Indian Health Service (IHS) on the Crow/Northern Cheyenne Reservation in southeastern Montana. After a long career as a Michigan licensed psychologist, she pursued psychopharmacology training beginning in 2007, completing Fairleigh Dickinson University’s post-doctoral clinical psychopharmacology master’s degree program in April 2010. After passing the APAPO Psychopharmacology Examination for Psychologists (PEP) and completing the physical assessment training and supervised clinical experience required under the New Mexico statute, she obtained a New Mexico conditional prescribing license in March 2013. In June 2013, she began her present job at an IHS full-service hospital which also offers dental, optical, primary care and behavioral health out-patient services, as well as emergency care, to 8,000 members of the Crow tribe who reside in and around the reservation. The Behavioral Health Department of the hospital includes three prescribing psychologists who actively and collaboratively provide services to every hospital department, to two satellite primary care sites within the reservation, and to community schools, law enforcement, and elder-care facilities.
Dr. Greenspan adores the practice of psychopharmacology and believes that prescriptive authority is the key to psychology’s future. She is devoted to RxP initiatives in the U.S and Canada, and has been an active member of the Ontario Psychological Association’s Prescriptive Authority Committee since 2010. She is involved in prescriptive authority efforts in Montana, recently meeting with Montana Governor Steve Bullock to discuss RxP initiatives. She is a member of APA Division 55 (American Society for the Advancement of Pharmacotherapy), as well as a member of the State Psychological Association of New Mexico (SPA-NM).
Dr. Diana Velikonja, Ph.D., C.Psych., is a licensed Neuropsychologist in Ontario. She completed her doctoral degree in Biological and Clinical Psychology at the University of Waterloo and completed a residency in Neuropsychology at McMaster University Hospital. She is a practicing Neuropsychologist in the Acquired Brain Injury Program at Hamilton Health Sciences, where she was the Chief of Psychology Practice from 2004 to 2011.
Dr. Velikonja has worked in the Acquired Brain Injury Program since 1996 providing assessment as well as developing treatment for patients suffering from mild to severe injury and impairment. She has also provided neuropsychological consultative services for a variety of pediatric, adult and geriatric neurologically impaired populations. She is also the Chair of Research in the ABI Program, and has been awarded research grants and published articles in the area of ABI.
Dr. Velikonja is an Assistant Professor in the Department of Psychiatry and Behavioural Neurosciences in the Faculty of Health Sciences at McMaster University. She is also a member of the Ontario Neurotrauma Foundation (ONF) Committee for Acquired Brain Injury, providing consultation for funding ABI research, and has been a member on a number of their expert panels, including development of guidelines for the assessment and treatment of traumatic brain injury. She is a former member of the Ontario Psychological Association's Board of Directors, and currently Co-Chair of the OPA Prescription Privileges Committee. Dr. Velikonja is also on the Board of the Hamilton Brain Injury Association.
Dr. Velikonja is a founding partner of Storrie, Velikonja & Associates (SVA), a full-service psychology clinic located in Burlington, Ontario, and Co-Director of the SVA Concussion Clinic and SVA Healthy Aging Clinic.
Dr. H. Jane Storrie, Ph.D., C.Psych., received her PhD from the University of Waterloo in Biological and Clinical Psychology and completed an internship in Clinical Neuropsychology at Hamilton Health Sciences/McMaster University. She is a member in good standing with the College of Psychologists in Ontario, with declared areas of competence in clinical, rehabilitation, and clinical neuropsychology.
Dr. Storrie is Present-Elect of the Ontario Psychological Association (OPA), and a former President of the Canadian Academy of Psychologists in Disability Assessment (CAPDA). She holds the appointment of Assistant Professor in the Faculty of Health Sciences, Department of Psychiatry and Behavioural Neurosciences, at McMaster University, and was awarded Diplomate Emeritus status by the American Board of Disability Analysts (ABDA).
She is a member of the Hamilton Health Sciences/McMaster University Psychology Internship Committee, and is the facilitator of the internship program's Ethics and Professional Practice seminars. Dr. Storrie is Co-Chair of the OPA Prescription Privileges Committee, the OPA Programs Committee, and the OPA Communication Committee, among others. She is a Director of the Hamilton Medical-Legal Society.
Dr. Storrie is a founding partner of Storrie, Velikonja & Associates (SVA), a full-service psychology clinic located in Burlington, Ontario, and Co-Director of the SVA Concussion Clinic and the SVA Healthy Aging Clinic.
This was the schedule of events for the workshop.
Registration & Breakfast 8:30 a.m. -9:30 a.m.
Welcome & Introduction 9:30 a.m. - 9:45 a.m.
Dr. Robert McGrath 9:45 a.m. - 10:30 a.m.
Dr. McGrath will provide historical context and an overview of the RxP movement, including the development of the APA curriculum, and the recommended requirements for prescribing privileges (post-doctoral MS degree in psychopharmacology, clinical supervised experience, PEP examination).
Dr. Marie Greenspan 10:30 a.m. - 11:15 a.m.
Dr. Greenspan will share her experiences obtaining the MS degree, completing her clinical supervised experience, and working as a conditional prescriber. She will also describe her involvement in the RxP movement in several states, providing some recommendations for Ontario based on her observations.
Break 11:15 a.m. - 11:30 a.m.
Dr. Diana Velikonja 11:30 a.m. - 12:15 p.m.
Dr. Velikonja will provide the background of the RxP movement in Ontario, the establishment of the OPA Prescriptive Authority Committee, the rationale for seeking prescription privileges for psychologists, the process for expansion of competency to include prescribing, and the development of the OPA submission to the Minister of Health (including stakeholder meetings).
Lunch 12:15 p.m. - 1:15 p.m.
Dr. Jane Storrie 1:15 p.m. - 2:00 p.m.
Dr. Storrie will provide an overview of the OPA submission to the Ministry of Health, the submission process, current status, ongoing initiatives of the Committee, and next steps. The participants will be advised as how to best advocate for prescriptive authority.
Panel/Q&A 2:00 p.m. - 3:00 p.m.